Dovato is indicated for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults with no known or suspected resistance to the integrase inhibitor class, or lamivudine (see Pharmacology: Pharmacodynamics under Actions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.